Jazz Pharmaceuticals (JAZZ) Beats Q2 Earnings and Revenue Estimates
JAZZJazz Pharmaceuticals(JAZZ) ZACKS·2024-08-01 06:46

Jazz Pharmaceuticals (JAZZ) came out with quarterly earnings of 5.30pershare,beatingtheZacksConsensusEstimateof5.30 per share, beating the Zacks Consensus Estimate of 4.68 per share. This compares to earnings of 4.51pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof13.254.51 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 13.25%. A quarter ago, it was expected that this drugmaker would post earnings of 4.14 per share when it actually produced earnings of $2.68, delivering a surprise of -35.27%.Over the last four quarters, the ...